SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies (BMNR) is generating intense market discussion following its significant new investment in Beast Industries and a widely scrutinized annual shareholder meeting. Investor sentiment is sharply divided, with extensive debate over whether the unconventional deal represents a strategic play for future engagement or a questionable capital allocation, particularly amidst a controversial proposal for substantial share expansion. This has placed the company's financial strategy and leadership under considerable investor focus, contributing to a perceived disconnect from its core Ethereum treasury performance.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Crypto is trending as its dedicated community fervently champions the "OG meme" narrative of Rage Comics, positioning it as a "foundational meme reset" for the current market cycle. This active base expresses strong conviction, building an ecosystem with platforms like RageMaker and RageGames, and urging enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings Ltd (SPHL) is trending due to its announced partnership with Jiangsu GSO New Energy for a solar-ready homes initiative in Singapore, igniting massive price action. The community is heavily discussing the stock's ultra-low float, propelling short squeeze speculation and comparisons to other high-volatility micro-caps that have yielded life-changing gains for traders.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is attracting significant attention for its advanced GaN and SiC power solutions, which are crucial for high-efficiency architectures in next-generation AI data centers, including NVIDIA's 800-volt ecosystem. The community is highly engaged, anticipating potential contract announcements and a significant short squeeze, fueled by substantial short interest, as the company repositions for AI-driven growth.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is currently trending as its CEO delivered a bullish presentation at a major healthcare conference, underscoring robust Miplyffa patient enrollment and an anticipated patent extension. This positive outlook, combined with a recent CFO departure and the appointment of a new board member with M&A experience, is fueling strong community speculation about a potential acquisition, even amidst discussions around a recent legal judgment against the company.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is experiencing significant market attention following a recent share consolidation that has drastically reduced its public float, creating a highly volatile trading environment. Traders are actively discussing the stock's potential for a massive short squeeze, drawing comparisons to other recent micro-cap runners. The community is focused on the low float and the company's expected accounting gain to achieve Nasdaq compliance, despite numerous trading halts.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials ($RGNT) is trending after securing a new U.S. patent for its GelrinC liquid formulation, a development that initially went under the radar. Retail traders are now intensely focused on its extremely low float and recent IPO status, driving widespread speculation for a significant short squeeze if volume escalates.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is actively trending due to its expanding partnerships in AI-powered commerce with major tech players and the integration of its PYUSD stablecoin by Interactive Brokers. This is sparking sharply divided community discussions, with many expressing frustration over the stock's persistent underperformance and perceived manipulation, while others highlight its deep fundamental value and strong position in the growing Buy Now, Pay Later market as catalysts for a future rebound.

Spell Token

Spell Token is trending as the crypto community eagerly anticipates a strong altcoin season, with discussions centered on potential market growth from evolving regulatory clarity and increased adoption. Enthusiasts are actively accumulating the token, driven by optimistic sentiment and expectations for significant upward movement.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is actively discussed after receiving regulatory approvals for its Renergen acquisition, integrating critical helium and LNG production. This news, coupled with broader market interest in nuclear energy for data centers and ASPI's partnership with TerraPower, is fueling community debate between optimism for its strategic positioning and frustration over commercialization timelines for other isotopes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunic (NASDAQ:IMUX) Shares Up 9.3% - Should You Buy?

Immunic (NASDAQ:IMUX) Shares Up 9.3% - Here's What Happened...

Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Buy" by Analysts

Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been assigned a consensus recommendation of "Buy" from the eight research firms that are presently covering the company, MarketBeat reports. One...

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December PR Newswire NEW YORK...

Analysts Offer Predictions for Immunic FY2025 Earnings

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Chardan Capital issued their FY2025 earnings per share estimates for Immunic in a research note issued to investors on Wednesday...

Equities Analysts Issue Forecasts for Immunic Q1 Earnings

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Brookline Capital Management issued their Q1 2026 earnings estimates for shares of Immunic in a research report issued to clients...

HC Wainwright Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00

HC Wainwright lowered their target price on shares of Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a research note on Friday...

Immunic (NASDAQ:IMUX) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Immunic (NASDAQ:IMUX - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.05...

D. Boral Capital Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00

D. Boral Capital reduced their target price on Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a report on Thursday...

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire NEW YORK...

Q3 Earnings Forecast for Immunic Issued By Roth Capital

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Equities researchers at Roth Capital issued their Q3 2025 EPS estimates for Immunic in a research report issued on Friday, November 7th. Roth Capital...

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.

Immunic Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$0.6389
Prev Close	$0.65
Open	$0.6801
Dividend Yield	0.00%
50-Day Moving Average	$0.6592
Beta	1.59
Avg. Volume	1.5M
PE Ratio	-0.74

52-Week High	$1.39
52-Week Low	$0.5062
Market Capitalization	$78.19M
EPS (Annual)	-$1.00
Price to Book	6.00
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

IMUX
Immunic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMUX News

IMUXImmunic Inc